Introduction
to over-ride the anti-inflammatory action of glucocorticoids, putting MIF at a key point in the regulation of Macrophage and T-cell infiltration occurs in virtually the inflammatory and immune responses. all forms of human glomerulonephritis [1] . The degree of renal impairment correlates with macrophage and T-cell accumulation, arguing that immune cellmediated injury is a common mechanism in the progression of glomerulonephritis. This hypothesis is supported by animal studies in which various depletion Macrophage migration inhibitory factor in strategies have demonstrated a pathological role for glomerulonephritis macrophages and T cells in experimental models of glomerulonephritis. We know little of the specific anti-MIF mRNA and protein are expressed constitutively gens involved in the cellular immune response within in many tissues [7] . The 12 kDa MIF protein is the kidney, therefore we reasoned that the best strategy encoded by a single gene and the protein product is for immune-intervention in glomerulonephritis is to stored within the cytoplasm, being released when cells target the molecules which operate at the pinnacle of are stimulated by factors such as lipopolysaccharide. the immune and inflammatory cascades. This led us to In normal kidney, MIF is expressed constitutively by study the role of MIF in kidney disease. some glomerular and tubular epithelial cells. During the development of rat crescentic anti-glomerular basement membrane glomerulonephritis, there is marked up-regulation of MIF expression by intrinsic kidney cells, including endothelium and glomerular and tubular epithelial cells [8] . Importantly, macrophage accumulation is localized exclusively in areas of strong
What is macrophage migration inhibitory factor?
MIF expression, contributing to focal glomerular and tubulointerstitial lesion formation. In preliminary Macrophage migration inhibitory factor (MIF ) was studies, we have also shown that MIF expression is first described as a product of activated lymphocytes up-regulated in human glomerulonephritis, with strong over 30 years ago, but the functions of this molecule MIF expression in areas of macrophage infiltration. are only now being delineated [2] . The importance of MIF in the induction of the skin delayed-type hypersensitivity (DTH ) response was recently confirmed in mice by administration of a neutralizing anti-MIF monoclonal antibody (mAb) [3] . In addition, MIF plays a central role in endotoxaemia and MIF collabor-The effect of anti-MIF antibody treatment on ates in primary T-cell activation [4, 5] . Furthermore, a experimental glomerulonephritis novel and potentially very important finding is the ability of MIF to counter-regulate the action of gluco-To explore the therapeutic potential of blocking MIF, we administered a neutralizing anti-MIF mAb in a rat model of crescentic anti-GBM glomerulonephritis.
Introduction Physiological stimuli for the release of EDHF
Receptor-dependent agonists have mainly been used Local vascular tone is generally determined by extrinsic and intrinsic mechanisms such as autonomic nerve to elicit the synthesis and characterize endotheliumderived vasodilator and constrictor substances, activity, circulating vasoactive compounds, tissue metabolites, the myogenic response and endothelium-although mechanical forces such as fluid shear stress and pulsatile stretch are more physiologically importderived autacoids. The best characterized autacoids are the potent vasodilators nitric oxide (NO) and ant stimuli for the continuous generation of the endothelium-derived autacoids. Recently the release of prostacyclin (PGI 2 ) and the vasoconstrictor peptide endothelin. Several studies have, however, convincingly EDHF, as assessed by the magnitude of the hyperpolarization of detector smooth muscle cells, was reported demonstrated the existence of an NO/PGI 2 -independent component of endothelium-dependent relaxation to be greater in response to pulsatile stretch than in response to supramaximal concentrations of bradyin mesenteric, carotid, coronary and renal arteries [1] . Since this NO/PGI 2 -independent vasodilatation was kinin [3] . Thus mechanical stimulation of arteries is likely to ensure the continuous release of this endothecoincident with vascular smooth-muscle hyperpolarization, the term 'endothelium-derived hyperpolarizing lium-derived vasodilator. factor' was coined. This term has proved somewhat misleading, as hyperpolarization was not initially monitored under conditions of combined NO synthase/ Putative nature of EDHF cyclo-oxygenase blockade; thus, the effects originally observed probably represent the combined actions of Is NO an EDHF? NO and PGI 2 as well as EDHF. Indeed, assigning High concentrations of NO have been reported to specific effects and second messenger pathways to each directly activate Ca2+-activated K+ ( K+ Ca ) channels of these autacoids is hampered by the fact that they and to induce smooth muscle hyperpolarization under can all be produced at one time in response to a single certain experimental conditions. However, whether stimulus. physiological concentrations of NO are able to induce the hyperpolarization of vascular smooth muscle cells, which is generally attributed to the actions of EDHF,
Is EDHF a transferable humoral factor?
was initially controversial [4] . While an NO/PGI 2 -mediated hyperpolarization can be evidenced in patch The existence of a humoral hyperpolarizing factor clamp experiments, more than 60% of the hyperpolarproduced by native endothelial cells was originally ization elicited by the intraluminal solution from proposed on the basis of an endothelium-dependent bradykinin-stimulated porcine coronary segments is hyperpolarization of vascular smooth-muscle cells in insensitive to combined NO synthase/cyclo-oxygenase an arterial segment. However, it proved difficult to blockade. This residual hyperpolarization is unaffected substantiate the release of a diffusible hyperpolarizing by either oxyhaemoglobin or selective soluble guanylyl factor using classical bioassay techniques. Evidence cyclase inhibitors which abrogate NO-mediated dilatathat EDHF is indeed a transferable factor has recently tion [5] . Moreover, the production of EDHF is actually been obtained by monitoring the membrane potential inhibited by basally produced NO and only under of detector vascular smooth muscle cells situated down-conditions of impaired NO synthesis can a distinct stream from, and electrically isolated from, donor EDHF-like response be demonstrated [5] . These conendothelial cells [2] .
siderations, taken together with the pharmacological characterization discussed below, suggest that the Correspondence and offprint requests to: Dr Rudi Busse, Institut fü r 'endothelium-dependent' hyperpolarization observed Kardiovaskuläre Physiologie, Klinikum der J. W. GoetheUniversität, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany. in response to agonists and mechanical stimulation is Nephrol Dial Transplant (1998) 13: Editorial Comments 2722 elicited by a hyperpolarizing factor which is distinct interference of one autacoid with the synthesis of another has been difficult to study. However, under from NO and PGI 2 . conditions of combined NOS/COX blockade, physiological concentrations of NO-whether generated by Pharmacological characteristics of EDHF the endothelial and the inducible NO synthases or Although the exact chemical nature of EDHF is exogenously applied NO donors-are able to attenuate unknown, the hyperpolarizing factor produced by EDHF-mediated relaxations. Using a patch clamp carotid, coronary, and renal arteries displays character-bioassay for EDHF, it has been demonstrated that istics similar to those of a cytochrome P450-derived NO attenuates the synthesis of EDHF rather than metabolite of arachidonic acid [6, 7] . Inhibitors of interfering with its ability to activate K+ Ca channels in cytochrome P450 enzymes, such as micodazole and detector vascular smooth muscle cells [5] . Similarly, 17-ODYA, markedly attenuate EDHF-mediated cytochrome P450 activity in endothelial cells can be relaxation in a number of vessels. Moreover, induction attenuated by NO by two mechanisms; an acute effect of cytochrome P450 enzymes using b-naphthoflavone involving either a decrease in [Ca2+] i and/or interaction enhances the release of EDHF from cultured porcine with the prosthetic haem group of the enzyme, and a and human endothelial cells [2] . Although concern has chronic effect which results in the decreased expression been expressed regarding the non-selective effects of of P450 protein [5] . Pro-inflammatory cytokines, which some P450 inhibitors (i.e. clotrimazole and econazole) induce the expression of the inducible NO synthase in on K+ Ca channel activity and endothelial Ca2+ signal-porcine aortic endothelial cells, and the prolonged ling, it should be stressed that 17-ODYA exhibits incubation of endothelial cells with NO donors neither of these effects and has been shown to select-decrease the expression of cytochrome P450 (CYP) 2C ively inhibit the production of EDHF rather than and the release of EDHF [11] . It is therefore likely interfere with its action on smooth muscle cells [2] . that the production of EDHF is attenuated by NO These observations along with others led to the pro-under physiological conditions, but serves as a backposal that the EDHF released from the coronary and up system when NO synthesis is impaired. renal artery endothelium is most probably an epoxyeicosatrienoic acid ( EET ) synthesized by a cytochrome
Actions of EDHF
P450 epoxygenase. Indeed, EETs are generated by endothelial cells and mediate part of the dilator effect of arachidonic acid [8] . Moreover, 11,12-EET and EDHF-induced hyperpolarization is brought about by 5,6-EET induce K+ Ca channel inhibitor-sensitive an increase in the K+ conductance of vascular smooth relaxations of endothelium-denuded arteries and activ-muscle cells and is abolished in the presence of depolarate large conductance K+ Ca channels in native and izing concentrations of KC1. Inhibitors of K+ Ca cultured smooth muscle cells. channels, such as tetrabutylammonium, apamin, It is, however, likely that more than one EDHF charybdotoxin, or iberiotoxin, virtually abolish the exists since the hyperpolarizing factors released from EDHF-mediated relaxation, whereas glibenclamide, an the human gastroepiploic artery, guinea-pig carotid, inhibitor of ATP-sensitive K+ channels ( K+ ATP ) usuand rat mesenteric and hepatic arteries or the rat portal ally has no inhibitory effect. Patch clamp experiments vein exhibit very different pharmacological character-have shown that EDHF activates K+ Ca channels in a istics from that of the 'coronary EDHF' [1] . There is, cell-attached mode, i.e. when the channel under investihowever, evidence to suggest that EETs may be incorp-gation is isolated from the extracellular medium by the orated into and stored in endothelial membrane lipids, pipette. Thus it would appear that this factor activates to be released upon cell stimulation [9] . Such a mechan-K+ channels in an indirect manner, possibly involving ism may account for the apparent insensitivity of membrane-associated second messengers [2, 12] . In EDHF-mediated relaxations to the acute application addition to K+ Ca and K+ ATP channels, involvement of of P450 inhibitors. The endogenous cannabinoid anan-the Na+/K+-ATPase in EDHF-mediated relaxation damide was proposed as an EDHF in rat mesenteric has been inferred from the inhibitory effect of ouabain. vessels, since a selective CB1 cannabinoid receptor However, the effect of ouabain on EDHF-mediated antagonist attenuated relaxations mediated by 'authen-relaxations is the result of direct depolarization of the tic EDHF' [10]. However, although anandamide and smooth muscle cell membrane which offsets any endothe CB1 agonist HU 210 induce the relaxation of a thelium-dependent hyperpolarization. range of vessels by a cyclo-oxygenase-dependent mech-20-Hydroxyeicosatetraenoic acid (20-HETE ), an vanism, these compounds did not induce an EDHF-hydroxylation product of arachidonic acid catalysed like (NGnitro-L-arginine/diclofenac-insensitive, K+ Ca by cytochrome CYP 4A, has been proposed to be channel-mediated) dilatation.
involved in the development of myogenic tone [13] . 20-HETE is endogenously produced by smooth muscle cells from small renal and cerebral vessels, and once
Interactions between NO and EDHF
formed it increases smooth muscle tone by inhibiting large-conductance K+ Ca channels, inducing depolarization and increasing [Ca2+] i , probably by activating Since a pure EDHF response can only be observed in the presence of NGnitro-L-arginine and diclofenac, the L-type Ca2+ channels [13] . NO may also modulate Nephrol Dial Transplant (1998) 13: Editorial Comments 2723 coronary arteries: a modulator of arterial compliance. Circ Res the formation of 20-HETE by binding and inactivating 1998; 81: 696-703 the cytochrome P450 haem moiety in much the same 4 . Cohen RA, Plane F, Najibi S, Huk I, Malinski T, Garland way that it inhibits the 'EDHF synthase'. It is tempting 
Proteinuria is an important risk factor for renal
and that this phenomenon was independent of the prognosis nature of any underlying diseases or blood pressure A recent report from GISEN (Gruppo Italiano di [1] . Patients with a low baseline urinary protein excreStudi Epidemiologici in Nefrologia) clearly demon-tion rate (<1.9 g/24 h) had the lowest rate of GFR strated that the decline of glomerular filtration rate decline and progression to the end-stage renal failure ( ESRF ) (4.3%) during~3 years of follow-up. In
Correspondence and offprint requests to: Seiichi Matsuo, MD, contrast, patients with nephrotic-range proteinuria Division of Nephrology, The Third Department of Medicine, (>3.9 g/24 h) lost kidney function rapidly and 32.5% Nagoya University School of Medicine, 65 Tsurumai-cho, Showaku, Nagoya 466, Japan.
of patients reached ESRF. Thus, the authors concluded that urinary protein excretion was the best single is needed to see whether ACE inhibitors may reduce urinary excretion of macromolecular complement compredictor of renal disease progression. However, there ponent such as C3. is general agreement that the degree of tubulointerstitial injury correlates well, not only with renal function at the time of biopsy [2] but also with functional outcome of the kidney [3] . The possible link between Complement is activated on the apical surface of proteinuria and tubulointerstitial injury is the presence proximal tubular cells and alters the functions of of filtered plasma proteins in the tubular lumen. Until tubular cells to induce tubulointerstitial injury now, numerous plasma proteins have been demonstrated to affect the tubular cells and promote tubuloin-
The classical work of Sato and Ullrich [13] showed terstitial injuries. These include albumin [4] , transferrin that isotonic reabsorption by rat kidney proximal [5] and lipoproteins [6 ] . Complement is one candidate tubule was inhibited drastically after short perfusion for the promotion of proteinuria-associated tubular with fresh sera from rats or other species. They further injury [7] . The evidence supporting the role of filtered extended their work to show that complement is complement has been shown in both in vivo and in involved in this phenomenon although the precise vitro studies. mechanism of complement activation was unknown [14] . Camussi et al. [15] demonstrated, using fresh frozen sections of normal human kidneys, that the brush borders of proximal tubules activate an alternat-
Selectivity of proteinuria and glomerular filtration
ive pathway of complement. Biancone et al. [16 ] of complement further promoted an in vitro study to confirm Camussi's observation using normal human proximal tubular The composition of plasma proteins filtered through cells in culture. Production of reactive oxygen species the glomerulus into the tubular lumen in proteinuric was increased when human proximal tubular cells were patients is dependent on the perm-selectivity of the exposed to 25% fresh human serum. Heat-inactivated glomerular barrier. Among complement components or C6-deficient serum failed to induce this phenomof the activation sequence (C1-C9, factor B and factor enon. In addition, human umbilical vein endothelial D), the largest is C4 at 206 kDa and the second largest cells (HUVEC ) did not produce reactive oxygen are C1r, C3 and C5 at 180 kDa. C8 has a molecular species under the same situation suggesting that the mass of 163 kDa. As far as the molecular size is proximal tubular brush border has an as yet unknown concerned, the key molecules in the alternative and mechanism of complement activation and MAC late pathways such as C3, C5 and C8 seem hardly to formation on their surface. be filtered through the glomerular barrier in patients
In order to see the in vivo role of complement in with selective proteinuria. In contrast non-selective the proteinuria-associated tubulointerstitial injury, proteinuria may contain various plasma-derived Nomura et al. [17] performed an experiment using macromolecules, but the precise composition of the aminonucleoside nephrosis rats. Depletion of serum urinary protein components according to the degree complement by cobra venom factor or regulation of of selectivity has not been studied fully. The pioneering complement by intraperitoneally administered soluble work of Ogrodowski showed that urinary excretion of complement receptor type 1 (sCR1) decreased significmembrane attack complex (MAC ), the final product antly the deposition of C3 and MAC on the apical of the complement activation pathway, is increased membrane of the proximal tubular cells and tubulosignificantly in patients with complement-independent interstitial injury without affecting the level of proglomerular diseases such as focal glomerular sclerosis teinuria. Since the injected sCR1 was detected in the and diabetic nephropathy [8] . MAC is a complex urine and was also observed on the brush border of molecule (C5b-9) with a large molecular size, and the proximal tubule where C3 was deposited, intraperiintravenously injected MAC is hardly filtered through toneally administered sCR1 was filtered into the tubuthe glomerular barrier even in the nephrotic condition lar lumen and inhibited locally the further activation [9] . Thus, the presence of MAC in the urine is thought of complement on the tubular brush border where C3 to indicate not only the presence of leaked complement activation was taking place. Morita et al. [18] obtained in the tubular lumen but also the intratubular activa-similar results using a different model of proteinuria tion of complement. The only exceptions are the human associated tubulointerstitial injury. Thus, activation of membranous nephropathy [10] and rat Heymann complement in the tubular lumen leads to the tubulonephritis [11] . In these conditions, it is hypothesized interstitial injuries in proteinuric conditions. that MAC is initially formed on the podocytes, endocytosed into the cytoplasm, and finally shed into the urinary space.
Mechanism of complement activation and its
From the therapeutic point of view, one of the renoregulation in the tubulointerstitium protective effects of angiotensin converting enzyme (ACE) inhibitor is to reduce the abnormal glomerular traffic of macromolecules through improvement of In our bodies, complement activation via an alternative pathway takes place spontaneously by the interaction glomerular size selectivity [12] . Further investigation of the C3 molecule with water and ammonia. The factor, CD55) and HRF20 (20 kDa homologous restriction factor, CD59), was studied by Ichida et al. internal thiolester bond of C3 is cleaved and exposed [24] in the normal human kidney. Complement reguby this interaction, and C3 becomes an active form lators at C3 level (DAF and MCP) were hardly which has the ability to bind to cell membranes. detectable in the apical membranes of proximal tubular Activated C3 (C3i) can also bind factor B, and factor cells. This finding partially explains why the alternative B in the C3i-B complex is susceptible to factor D, pathway is activated on the apical surface of proximal resulting in the formation of C3i-Bb complex. This tubular cells when there is non-selective proteinuria, complex acquires the ability of C3 convertase which or when proximal tubular cells in culture are exposed cleaves an intact C3 molecule into C3a and C3b. C3b to fresh serum. behaves like C3i and generates a new C3 covertase, These in vitro and in vivo studies provide convincing i.e. C3bBb, and forms an enhancing cycle of C3 evidence for the role of complement in the proteinuria activation [19] . If there is no regulatory mechanism at associated tubulointerstitial injury. this step, complement activation continues until all the C3 molecules are consumed. Complement regulators in both cell-membrane-bound and serum-soluble forms play crucial role in the regulation of complement activation.
Local (extra hepatic) production of complement Complement activation proceeds when enhancing components in the kidney factors for complement activation overcome inhibiting factors. In the kidney, there are number of enhancing Although the main source of most serum complement factors for complement activation. First, ammonia components is liver, many studies have demonstrated production per unit nephron is increased when there that various complement components are also prois proteinuria, metabolic acidosis and significant loss duced in extra-hepatic organs or cells. A number of in of functioning nephrons [20] . However, ammonia vitro studies demonstrated that several complement excretion into the urine is decreased when there is components including C2, C3, C4 and factor B are tubulointerstitial injuries including polycystic kidney generated by renal cells under normal conditions, and diseases [21] . As a consequence, the local concentration their production is up-regulated by inflammatory cytoof ammonia might be increased to activate C3. kines [25] . In an experimental model of murine lupus Secondly, it has been reported that the functioning nephritis, the increase in renal production of complefactor D is increased markedly in the urine of patients ment components C2, C3, C4 and factor B correlated with chronic renal failure [22] . This may also promote with the severity of nephritis [26 ] . Internal C3 synthesis acceleration of intratubular C3 activation in pro-has been shown to increase in immune complex glomteinuric patients with renal failure. All enzymes pro-erulonephritis [27], tubulointerstitial nephritis [28] and moting C3 activation belong to a serine protease entity. allograft rejection [29] . In human renal allografts, donor-specific C3 was expressed and localized in glomAlthough many substances with serine protease erulus and tubule [30] . These findings strongly suggest activity have been reported to exist in the apical that locally produced complement components conmembrane of renal tubules, no information is available tribute to the progression of renal inflammation. to date concerning their ability to promote C3 Timmerman, however, has attempted to elucidate activation.
the role of locally synthesized C6 in the kidney As for the protection against complement activation by administering anti-rat Thy1.1 antibody to a in the tubules, there are two mechanisms to be discus-C6-deficient rat (PVG/c− strain) transplanted with a sed. The first is the high concentration of urea. It kidney from a wild-type C6-sufficient rat (PVG/c+ inhibits activation of complement at the C3 level [20] . strain) [31] . Transplanted kidney expressed C6 mRNA It is probable that urea concentration is disturbed in in peritubular sites, but there was no C6 or MAC tubulointerstitial injury and this may lead to the further deposition in the glomerulus. Since anti-Thy1.1 nephactivation of complement. The second is the membrane ritis is dependent on MAC, the authors concluded that regulator of complement. Importance of membrane the renal synthesis of C6 was not sufficient to produce bound complement regulator was demonstrated by the glomerular injury. Thus, the role of complement comwork of Nomura et al. [23] . The function of C3 level ponents produced locally in the kidney is not concluscomplement regulator (rat Crry) was first inhibited by ive. Further efforts are needed to elucidate the role of Fab fragment of a specific monoclonal antibody by locally produced complement components in the develkidney perfusion. When the kidney was connected to opment of tubulointerstitial injury. the systemic circulation again, significant complementdependent tubulointerstitial injury was induced. Thus, rat Crry was considered to play an important role in protecting the kidney from the autologous complement Introduction ized a Na+-P i cotransporter cDNA from rat parathyroid glands. Parathyroid hormone (PTH ) regulates the serum phosphate (P i ) concentration through its effect on the kidney to decrease P i clearance and increase serum P i , Cloning of parathyroid Na+-P i cotransporter which becomes an important problem in severe renal In a previous study, we isolated a Na+-P i cotransporter failure. Clinical studies have demonstrated that P i cDNA from rat parathyroid glands [9] . The protein restriction in patients with chronic renal insufficiency encoded by this cDNA clone, rat PiT-1, showed Na+-is effective in preventing the increase in serum PTH dependent P i cotransport activity when expressed in levels. A number of careful clinical and experimental Xenopus oocytes and appears to be the homolog of studies have suggested that the effect of P i on serum human and mouse PiT-1 (Glvr-1), a Na+-P i cotrans-PTH levels is independent of changes in the levels of porter from mice and humans that also functions as a both serum calcium and 1,25-dihydroxyvitamin D 3 virus receptor ( Figure 1 ). The rat PiT-1 sequence
shares weak homology with pho-4+, a gene implicated In addition, Almaden et al. [5] showed that high P i in phosphate uptake in Neurospora crassa and directly stimulated both PTH secretion from whole rat also distantly related to partially characterized genes parathyroid glands in culture and PTH mRNA levels from Escherica coli, Streptomyces haslstedii and in human parathyroid tissue in culture. Slatopolsky Methanobacterium thermoautotrophicum. PiT-1 and et al. [6 ] showed similar results for PTH secretion pho-4+ display similar hydropathy plots, contain simfrom rat parathyroid glands maintained in primary ilar internal repeats, and are homologous in their culture. These results indicate that P i regulates the primary structures. This family of high-affinity P i transparathyroid directly.
porters allows cells to grow under restrictive conditions This effect of P i may be mediated by specific molec-requiring a high-affinity uptake of P i . Thus, PiT-1 is a ules in the parathyroid cell membrane or by metabolic member of an ancient P i transporter gene family. signals associated with increased cellular P i concentrations. One such mediator may be a Na+-dependent P i Characterization of a parathyroid Na+-P i cotransporter cotransporter in the plasma membrane of parathyroid cells.
To characterize the Na+-dependent P i cotransport system in rat parathyroid glands, we measured the Mammalian Na+-P i cotransporters initial rate P i fluxes over a wide range of P i concentraAt least three types of Na+-P i cotransporter have been isolated from mammalian cells [7, 8] . Type I and type II transporters have been isolated from kidney cortex; they mediate Na+-dependent P i cotransport in the apical membrane of proximal tubular cells. Type III transporters were isolated as receptors for gibbon ape leukemia virus (GLVR1 or PiT-1) in mice and humans and amphotropic murine retrovirus (Ram-1 or PiT-2) in rats, and were shown to serve normal cellular functions as Na+-dependent P i cotransporters in several tissues [8] . PiT-1 and PiT-2 are approximately 60% identical in amino acid sequence, and exhibit no significant overall sequence homology with the type I Correspondence and offprint requests to: Ken-ichi Miyamoto, PhD, Fig. 1 . The predicted structure of the parathyroid Na+-P i cotransDepartment of Clinical Nutrition, School of Medicine, Tokushima University, Kuramoto Cho 3, Tokushima City 770, Japan.
porter PiT-1. The 10 predicted transmembrane regions (M1-M10).
tions [9] . In the absence of Na+ in the incubation apical Na+-P i cotransport activity, and increasing the P i concentration leads to lowered P i uptake [10, 11] . It medium, the transport of P i was significantly reduced, amounting to <55% of the total uptake. The kinetic was found that the adaptive response to P i deprivation can be elicited only when the apical side of the cells is values for the Na+-dependent P i transport system in rat parathyroid glands were similar to those for PiT-1, in contact with a low P i medium [11] . The up-regulation of the apical P i transport is apparent suggesting that PiT-1 is a functional Na+-dependent P i transporter in rat parathyroid glands. The significant within 2 h of replacement of the 'normal' medium with a low P i medium. Replacing the basolateral medium difference in K m values (89±13 and 140±20 mM, P<0.05) observed between parathyroid glands and with a low-P i medium has no effect on the apical adaptation. In addition, the basolateral Na+-independXenopus oocytes could be the result of uncontrolled variables, such as membrane potential or post-ent P i transport does not undergo an adaptive response, whether the low P i medium is on the apical side or the translational modifications [9] . basal side. Based on these data, it can be speculated that changes in the intratubular P i concentration are Regulation of parathyroid Na+-P i cotransporters the determining factors for the adaptive response [11] . The amount of PiT-1 mRNA in the thyroparathyroid This signal may stabilize the Na+-P i cotransporter tissue was reduced in vitamin-D-deficient animals com-mRNA [7] . These observations suggest that apical pared with that in normal animals. When expressed Na+-P i cotransporters may act as the P i -sensing prorelative to the amount of glyceraldehyde-3-phosphate tein in renal epithelial cells. dehydrogenase (GAPDH ) mRNA, the administration of 1,25(OH ) 2 D 3 to vitamin-D-deficient rats induced Parathyroid cells 2.3-and 3.3-fold increases in the amount of PiT-1 mRNA in these glands after 24 and 48 h, respectively We suspect that a Na+-P i cotransporter may mediate the effects of extracellular P i on the regulation of PTH [9] .
Rats fed a low-P i diet for 14 days showed a markedly synthesis. This transporter was regulated by 1,25(OH ) 2 D 3 and by dietary P i , but there is no evidence lower plasma concentration of P i than animals fed a high-P i diet for the same period [9] . When expressed that the extracellular P i needs to be taken up to exert its effect on the regulation of PTH synthesis. Further relative to the amount of GAPDH mRNA, the amount of PiT-1 mRNA in the thyroparathyroid tissue of rats studies are needed to clarify whether PiT-1 functions as a cell-surface P i -sensing protein in parathyroid cells. fed the low-and control-P i diet was 3.2 and 2.5 times that of the animals fed the high-P i diet, respectively Nuclear transcript run-on assays showed that the effect of low P i was post-transcriptional, unlike the [9] . The level of PiT-1 mRNA in the parathyroid glands was also decreased in chronic renal failure predominantly transcriptional effect of 1,25(OH ) 2 D 3 on the PTH gene. Changes in the extracellular P i (CRF ) rats ( Table 1) .
concentration may modulate the stability of PTH mRNA ( Figure 2 ). In addition, the effect of calcium
How cells sense P i
on PTH secretion from dispersed bovine parathyroid cells occurs within seconds. However, the effect of P i
Renal proximal tubular cells
Changes in the extracellular concentration of P i modulate cellular function in a physiologically relevant manner. High extracellular P i concentrations inhibit and low concentrations stimulate 1,25(OH ) 2 D 3 synthesis in the renal proximal tubules. Extracellular P i also molulates the renal tubular reabsorption of P i , with reduced P i enhancing and increased P i diminishing the tubular reabsorption of P i [7] . Extracellular P i directly controls the apical Na+-P i cotransporter in the proximal tubular cells.
In opossum kidney proximal tubular cells (OK cells), a lowering of the medium P i results in an increase in acute tubulointerstitial nephritis results in transient massive proteinuria, haematuria, and decreased glom-so far been associated with human disease. Neither is erular filtration. Host genetic factors influence the another newcomer, Topografov ( TOP) virus carried clinical severity of NE [2] . DOB virus causes a more by lemmings (Lemmus lemmus). However, epidemiosevere form of HFRS than PUU virus. However, both logical data suggest that TOP or a related virus could infections may be subclinical.
have caused the lemming-borne military outbreak in Diagnosis of hantavirus infections is based on sero-Finnish Lapland during World War II. logy and reliable diagnosis requires demonstration of specific IgM or low avidity IgG antibodies.
Hantavirus infections in European countries
Traditionally, detection of antibodies has been based on immunofluorescence technique, but recently several EIA assays based on recombinant hantavirus nucleo-NE was first described in 1934 in northern Sweden. A capsid protein have been developed [3] . There is major probable hantavirus outbreak was reported in considerable cross-reactivity within the two major gen-1942 among Finnish and German troops mentioned etically related hantavirus groups (i) HTN/SEO/DOB above when hundreds of cases were seen. In viruses and (ii) PUU/TUL/SN-like viruses. Therefore Scandinavia most NE cases are reported in Finland at least two antigens, preferably PUU and DOB in (1000/year, incidence 19 per 100 000), while in Sweden Europe, are needed to detect all hantavirus infections. 100-300 and in Norway 50-200 clinical cases have occurred annually. In France, Belgium, the Netherlands, and Germany
Hantaviruses and carrier rodents
HFRS cases were first reported in 1982 to 1986. In an endemic forested area across the border between Most hantavirus infections in Europe are caused by France and Belgium epidemics occurred in 1990, 1993 PUU virus, carried by the bank vole (Clethrionomys and 1996. Over the past 10-12 years, the endemic glareolus), which is found almost everywhere in Europe areas in these countries have not been expanding. The except southern Spain and Italy and northernmost recent increase in diagnosed cases of NE in the Norway. The incidence of NE in humans depends Netherlands is possibly due to increased awareness of strongly on the pattern of population dynamics of the the disease amongst the medical profession [5]. The bank vole, which differs greatly in various parts of seasonal distribution in western Europe includes a Europe.
minor winter/spring peak and a major summer/autumn In northern Europe, the bank vole exhibits propeak. Most infections in these countries are caused by nounced 3-4 year population cycles, which are thought PUU virus but the first clinical case caused by DOB to be caused by rodent predators. Most human NE virus was recently reported in Germany. The number cases occur in the increase and peak phases of the of diagnosed annual infections in Germany is over 200 cycle. These cycles are not, however, synchronous over but there are probably a large number of unrecognized the whole country like Finland and Sweden, and clinical cases [1] . epidemics are encountered in different parts of the HRFS has been known in the Balkans since 1954. country during different years.
Hundreds of cases have been reported during the last In temperate Europe, on the other hand, the bank few years. In Bosnia more than 300 patients were vole populations are much more stable, basically seaadmitted to Tuzla hospital in 1995. Several factors sonal, increasing in summer and declining in winter.
such as presence of military camps with large amounts In these normal years NE is quite rare. However, of food stored under primitive conditions, inadequate occasional mast years, heavy seed crops of oak and garbage disposal, or the general breakdown of hygiene beech, are followed by improved survival and breeding caused by the war may have resulted in a higher of seed-eating rodents like bank voles. The mast years density of rodents. Most infections in the Balkans are are induced by higher than normal summer tempercaused by PUU virus. DOB virus has, however, caused atures and because of this, they can be synchronous severe HFRS in Slovenia, Albania, Greece, and Bosnia over large areas in Europe, consequently giving rise to [6, 7] . According to a recent survey of sera from human epidemics of NE.
patients with HFRS in Bosnia and Herzegovina, 75% DOB virus infections were originally reported only of the infections were caused by PUU and 25% by in the Balkans, but recently also in central Europe, DOB virus, whereas no signs of HTN or SEO virus Estonia and Russia [4] . DOB virus is carried by the infections were found [7] . striped field mouse (Apodemus agrarius) and yellowIn Russia, HFRS is a common disease, although necked forest mouse (A. flavicollis). Apodemus agrarius with varying incidence in various parts of the country. is not found in westernmost Europe and DOB virus PUU virus exists in western Russia and the highest carried by it seems to dominate in central, eastern and incidences of NE are found in Ural, Volga and Viatka northern Europe up to Estonia while DOB virus in territories with highest morbidity in Bashkiria (43 per Apodemus flavicollis seems to dominate in southern 100 000). That area experienced last year an outbreak Europe, especially in the Balkans.
with 4377 NE cases and 0.6% mortality. In the Far In Europe SEO virus has so far been proved East, more severe HFRS is recognized, probably to cause only infections transmitted by laboratory caused by HNT virus. Moreover, an outbreak of DOB rats. TUL virus, found in European common voles (Microtus arvalis), can rarely infect man, but has not virus-caused disease was recently reported from Russia. ation of PUU virus infection and chronic renal damage Antibody prevalence and risk groups [1, 5] Hantaviruses are the aetiologic agents of systemic i.e. adult respiratory distress syndrome (ARDS) [1] . The appearance of hantavirus infections in regions diseases with renal involvement ranging from the where this disease had so far not been observed, e.g. haemorrhagic fever with renal syndrome (HFRS) to North and South America reveals that the distribution the more benign nephropathia epidemica (NE ). Recent of hantaviruses and particularly of serotypes with high observations indicate that hantaviruses do not only virulence, is geographically more widespread than cause renal disease but also acute respiratory failure, thought in the past. The high genetic diversity of hantaviruses implies that genomic changes may lead to changes in the severity of the disease. Therefore, it Correspondence and offprint requests to: Professor E. Ritz, Sektion is well justified that the hantaviruses have been grouped Nephrologie, Med. Universitatsklinik, Bergheimer Str. 56a, D-69115 Heidelberg, Germany.
as 'emerging viruses' [2] . of pathogenicity of different hantaviruses with renal Global warming will generally cause a shift in the and pulmonary tissue tropism are still not understood. ecology of vectors leading to a shift in the epidemiology One can assume that different cellular and viral factors of vector-born disease, for example malaria tropica.
are involved in those molecular mechanism determinIt is also a chilling prospect that viruses of the ing the virulence, pathogenicity and tropism of hantahaemorrhagic fevers are considered likely candidates viruses. Although Black Creek Canal virus and Bayou for use in bioterrorism [5] .
virus belong to the New World hantaviruses (Sin From a clinical point of view it is even more importNombre virus group) renal failure is frequently ant that, in contrast to past opinion, molecular evidobserved. Furthermore it is known that the Old World ence shows that the virus is transmitted from person hantaviruses can cause pulmonary symptoms, too [10] . to person [6 ] . These observations in Argentina conSo there is more overlap of pulmonary and renal cerned the highly pathogenic Andes virus causing HPS, symptomatology than previously thought. but this possibility of virus transmission should also Sin Nombre virus strains are genetically more related be considered when caring for patients who are infected to Puumala virus than to Hantaan virus. As far as the with other types of hantaviruses.
genetic diversity of hantaviruses is concerned, genetic drift and shift and intramolecular recombination and
Virus subtypes and clinical course
rearrangement seem to play an important role in this process. Reassortment was recently reported for closely related strains of Sin Nombre virus [11] . The distribuUntil the beginning of this decade, three clinically relevant distinct hantavirus serotypes were recognized, tion of HPS infection throughout the world became a matter of concern since person-to-person transmission i.e. Hantaan, Seoul, and Puumala virus. Puumala virus is transmitted via C. glareolus and causes nephropathia is apparently possible. This fact raises the question whether or not HPS may occur in other parts of the epidemica, i.e. self-limited systemic disease with acute renal failure. In contrast, Seoul and Hantaan viruses world, e.g. in Europe. In north-west Germany, two cases of hantavirus infection with severe pulmonary cause moderate to severe systemic diseases with haemorrhagic fever and multiple organ involvement in insufficiency and no renal involvement were reported [12] . Viral sequences were identified that were genetic-Treatment and prophylaxsis ally more closely related to Puumala strains Haellnaes B1 and Berkel. The authors concluded that hantavirus Ribavirin, a RNA inhibitory drug (chemotherapy) has variants in Germany cause moderate to severe HPS-been studied in a variety of interventional trials conlike disease. In general, a pulmonary involvement of ducted in different countries. When administered in different hantavirus serotypes causing HFRS is plaus-the initial stage of infection, it will abbreviate the ible from the pathogenetic point of view. This is due duration of infection and mitigate its course. Although to the fact that hantaviruses are acquired by inhalation, the need for a hantavirus vaccine is urgent an efficient therefore lung cells (alveolar epithelium, macrophages prophylactic system against hantavirus infection is still and endothelial cells) are the first target cells exposed missing. The strategies for development of a vaccine to the virus. Consequently the initial organ for virus should be based on the expression of immunogenic replication seems to be the lung. This is in agreement epitopes in pro-and eucaryotic expression systems, with the detection of hantaviral antigens in the lung generation of attenuated viruses, production of antitissue of persistently infected rodents.
gen-presenting, but replication-deficient, viruses or expression of viral fusion proteins using viral vectors for example as chimaeric hepatitis B virus core par-
Renal manifestations
ticles [14] . Viral antigens can be detected in kidneys, but are also expressed in liver, spleen, heart, brain and pituitary of infected humans. Hantaviruses typically cause interstitial nephritis. The pathology correlates with severity 
Background
AII's effect of enhancing glomerular permeability to macromolecules solely to its ability to raise glomerular The glomerular and tubular functions of the kidney capillary hydraulic pressure, more recent evidence sugare regulated by an intricate network of circulating gests that AII regulates the glomerular sieving function and locally produced hormones. These substances comindependently of its hemodynamic effects, by modulatprise proteins, peptides, lipids and amino acid-derived ing the cytoskeleton assembly of the podocytes and/or molecules, such as arginine vasopressin, angiotensin II the matrix network of the glomerular basement mem-(AII ), atrial natriuretic peptides, endothelin ( ET ), brane [2] . Increasing evidence suggests that AII conbradykinin, arachidonate metabolites and nitric oxide. trols renal sodium excretion not only by interfering Recent advances in molecular biology have further with renal hemodynamics and activating aldosterone elucidated the role of these substances in renal pathobiosynthesis, but also by directly regulating tubular physiology. In particular, genetically manipulated epithelial sodium transport. Indeed, AII acts predomianimals in which a hormone is either overexpressed nantly in the S1 segment of the proximal convoluted (transgenic) or eliminated (gene knock-out) have tubule to reduce intracellular cAMP, increase the served as powerful tools to dissect the often complex Na+/H+ antiport activity and ultimately enhance Na+ and overlapping actions of these substances in the reabsorption [3] . kidney. In parallel, they have also contributed to more Whereas AII has been recognized for years as the insights into the role of vasoactive mediators, such as major renal vasoactive hormone it is increasingly AII and ET, in the process of progressive tissue destrucrecognized that this is just one mediator of renal vasotion in chronic renal diseases. Given the limited theraconstriction in normal and disease states. Of crucial peutic options available for patients with renal disease relevance are other hormonal systems, one of which, who are losing kidney function, these advances have critically dependent on the synthesis and release of led to interest in defining strategies to better prevent vasoactive molecules, belongs to the ET family and renal-disease progression.
comprises three different peptide isoforms: ET-1, 2 and 3, encoded by three different genes [4] . Mature peptides derived by cleavage via an endothelin converting
AII and ET-1 as major renal vasoconstrictors
enzyme ( ECE ), a phosphoramidon-sensitive, membrane-bound metalloprotease, exert their effects by The renal vasculature and tubule epithelium synthesize, activating specific receptors. Of these ET A mostly mediand are sensitive to, a variety of circulating and locally ates vasoconstriction and proliferation, while ET B derived vasoactive mediators, allowing the kidney to receptor activation is coupled to both vasoconstriction modulate glomerular filtration rate (GFR) as well as and vasodilation. Renal vessels are peculiarly sensitive Na+ and water excretion. AII, the effector peptide of to the vasoconstrictive effect of ETs [5] . Thus injection the renin-angiotensin axis, shares many of the charac-of ET-1 into rats raises blood pressure and renal teristics associated with known endogenous modu-vascular resistance and consequently reduces RBF and lators of renal function, being a potent vasoconstrictor GFR [6 ] . The effect of ET-1 of enhancing systemic of the renal vascular bed. In vivo, AII contracts both blood pressure is fully abolished by a selective blockade afferent and efferent glomerular arterioles, modulating of the ET A receptor [7] . A non-selective ET A -and intraglomerular capillary pressure and ultimately glom-ET B -receptor antagonist is needed instead to prevent erular filtration [1] . In addition to its effects on the ET-1-induced renal vasoconstriction suggesting a relevglomerular microcirculation, AII also has a relevant ant role for the ET B receptor in the renal response to role in modulating the sieving of macromolecules by systemically administered ET-1, at least in the rat. systemic blood pressure but a substantial decrease in renal function and excretion of water and sodium [8] . of AII enhances functional ECE activity in vascular The receptor subtypes which mediate renal vasocon-smooth muscle and kidney via the ET A receptor, whose striction in response to ET-1 infusion in humans are expression is upregulated by AII in vascular smooth unknown at present. ET-1 has a direct effect on sodium muscle cells, cardiomyocytes and mesangial cells [13] . homeostasis and water balance which varies among Part of the mitogenic effect of AII is mediated by ET-1 species. In rats a low dose of ET-1 has a natriuretic as suggested by studies with monoclonal antibodies effect, while in dogs ET-1 reduces sodium excretion against ET-1 or drugs that block the ET A receptor. A because of a decrease in filtered load and/or renin-reciprocal regulation of AII and ET-1 on matrix proangiotensin stimulation. In humans, ET-1 at sub-tein synthesis and cell proliferation via ET A and AT 1 pressor doses has no effect on the Na+ excretion rate receptors has been suggested in rat mesangial cells while higher pharmacologic doses induce dose- [14] , AII inhibitors or receptor blockers diminishing dependent, long-lasting pressor responses which reduce the ET-1-mediated effects and vice versa. Consistent GFR and alter renal Na+ handling through a pressor data are available indicating that ET-1 in part mediates natriuresis which may or may not be associated with the increase in systemic blood pressure induced by AII a reduction in Na+ filtered load.
Healthy human volunteers infused with pharmaco-
[ [15] [16] [17] , a phenomenon dependent on the activation of ET A receptors. The observation that in normotensive rats a dose of ET-1 devoid of the pressor effect Both AII and ET-1 induce fibroblast proliferation enhanced arterial pressure when combined with a nonand extracellular matrix synthesis pressor dose of AII, would indicate that vascular ET-1 acts in synergy with AII in inducing vasoconstriction and regulating systemic blood pressure in health Importantly, AII modulates renal cell growth [9] and and disease. Whether ET-1 also contributes to the evidence is available that intrarenal renin-angiotensin effect of AII in impairing glomerular permeability to system (RAS ) activation, as it occurs in most renal macromolecules in animal and human proteinuric disease conditions, is almost invariably associated with nephropathies is, however, controversial. renal growth. This phenomenon, apparently linked to AT 1 receptor activation, depends upon a process of secondary up-regulation of TGF-b and collagen type IV [10] . Injection of AII into the renal artery led to a significant increase in the renal expression of c-fos and Egr-1, the immediate early genes whose activation Evidence for AII activation and the effect of ACE precedes cell proliferation. These findings may account inhibitors in experimental progressive for the observation that in vivo in rats chronic infusion nephropathies of AII promotes type IV collagen deposition into renal interstitium and precedes fibrosis. Of interest, angio-AII generated in the kidney constricts the efferent tensin converting enzyme (ACE) inhibitors limit the arteriole much more than the afferent arteriole, contribup-regulation of genes which favor renal cell growth uting to the elevated glomerular pressure implicated in and the deposition of extracellular matrix proteins the pathogenesis of most experimental and human and block compensatory renal hypertrophy in most renal disease. In experimental diabetes early in the animal models.
course of the disease glomerular hyperfiltration ET-1 is also a strong mitogen for mesangial cells develops depending on afferent arteriolar dilation, [11] and fibroblasts, and by favoring cell proliferation possibly due to chronic hyperglycemia or genetic also promotes mesangial matrix protein gene transcripabnormality. Rats with subtotal renal ablation also tion. This is documented by findings in rat cultured develop proteinuria and progressive deterioration of mesangial cells and fibroblasts where challenge with increasing concentrations of ET-1 enhances the rates renal function owing to high glomerular capillary of synthesis of mRNA for collagen type I, III and IV. pressure. A high-protein diet, by promoting an excess-ET-1, by activating mesangial cell phospholipase A 2 , ive formation of renin mRNA, further enhances glompromotes the release of arachidonic acid from mem-erular pressure and accelerates the decline in renal brane phospholipids, which in turn causes excessive function. Thus abundant evidence exists that local formation of thromboxane A 2 , one of the factors stimulation of RAS is uniformly deleterious to the involved in the synthesis of extracellular matrix kidney in animal models. proteins. ET-1 is also chemotactic for blood mono-ACE inhibitors, which reduce glomerular pressure cytes, a property which in vivo could contribute to the by dilating the efferent arteriole, limit the progression tubulointerstitial damage that accompanies most renal of renal disease in experimental diabetes as well as in diseases characterized by a progressive course [12] .
animals with renal mass reduction. More recent evidence has been provided that ACE inhibitors decrease blood pressure, limit proteinuria and slow the
Cross-talking between AII and ET-1
decline in renal function in other models including, male MWF/Ztm rats, puromycin nephrosis, passive Heymann nephritis (PHN ) and immune-mediated It is well known that AII stimulates the expression of the ET-1 gene in endothelial and renal cells. Infusion nephropathies [18] .
The protective effect of AII antagonists in diabetic Evidence for ET-1 up-regulation in progressive nephropathies of diabetic and non-diabetic type and non-diabetic human renal diseases
Gene expression and the renal synthesis of ET-1 are ACE inhibitors for the same level of blood pressure up-regulated in animal models of disease progression control are more renoprotective than other antihyper- [24] . Thus the remnant kidney model is characterized tensives also used in human nephropathies and this by a time-dependent increase in renal ET-1 gene appears to be linked to their property of lowering expression, as well as an increase in urinary excretion urinary proteins to a greater extent than conventional of the peptide, both correlating with progressive renal drugs [18] . Lewis et al. [19] found that patients with damage. Similar results were obtained in rats with insulin-dependent diabetes mellitus given captopril passive Heymann nephritis, an immune model of glomhad a lower incidence of doubling of serum creatinine erular disease resembling human membranous nephrothan those on conventional therapy over 4 years of pathy. Other studies have found an up-regulation of follow-up. A similar effect of ACE inhibitors was renal ET-1 and endothelin type B (ET B ) receptor gene shown in patients with immune-mediated chronic expression in NZB/W F 1 mice that have an immunolonephropathies [18] . That the superior renoprotection gical disease reminiscent of human lupus. Glomerular achieved by ACE inhibitors compared with other ET-1 and ET B receptor mRNAs were elevated (comdrugs depended on their effect of limiting the urinary pared with normal ) within days of puromycin aminoprotein excretion rate, even at comparable levels of nucleoside injection and decreased to control levels by blood-pressure control, has been documented formday 20, when the animals were no longer nephrotic. ally by the Ramipril Efficacy in Nephropathy ( REIN )
Data are also available in experimental diabetes where study. In this trial the mean rate of GFR decline was the mRNA for ET-1 is overexpressed in the face of three times lower in patients with baseline proteinuria unchanged ET A and ET B receptors. More direct evidof 1-3 g/24 h as compared with levels of Á3 g [20] .
ence for ET-1 as a fosterer of renal damage derives Among this latter group the rate of GFR decline was from studies using transgenic animals. Mice oversignificantly limited by ramipril as compared with expressing the human ET-1 promoter form more ET-1 conventional treatment. In the ACE inhibitor group in their kidneys and develop renal lesions despite not the GFR decline was associated with an early reducdeveloping hypertension [18] . Furthermore, rats transtion in the urinary protein excretion rate which genic for the human ET-2 gene are normotensive and remained significantly lower than in the control group are characterized phenotypically by renal lesions reminthroughout the whole study. In addition, the reduciscent of those seen in rats with remnant kidney [18] . tion in the risk reaching an end-point was significantly
Evidence for increased renal ET-1 is also available for predicted by the percentage reduction in urinary propatients with chronic progressive nephropathies and tein excretion during the treatment period as comfor unilateral nephrectomized patients. pared with baseline. In both treatment groups systolic and diastolic blood pressure were comparable at baseline, fell similarly after randomization and remained comparable during the whole follow-up. Chronic treatment with ACE inhibitors, however, does not suppress the formation of AII uniformly, the plasma ET-1 antagonists improve, at least partially, levels of which, after an initial fall, tend to increase diabetic and non-diabetic progressive nephropathies with time toward to baseline levels [21] . A possible explanation for the antihypertensive and renoprotective effects of this class of compounds rests on data In the renal ablation model both ET A , and ET A and which show that AII degradation products, in particu-ET B receptor antagonists partially reduced proteinuria, lar angiotensin [1] [2] [3] [4] [5] [6] [7] , are formed in excessive amounts ameliorated renal function and prolonged survival in the circulating blood of patients given ACE inhib-despite poor blood pressure control [24] . The renoproitors. These compounds act to oppose the pressor tective effect of ET A antagonists was also evident in action of AII by stimulating vasodilatory prosta-mice affected by a lymphoproliferative disease which glandins and nitric oxide. However, AII is known to mimics lupus, and in rats with experimental diabetes stimulate the generation of the vasoconstrictor pep-treated at the moment of induction of the disease. tide ET-1 and data are available which show that in More recently, an unselective endothelin-receptor antanimals with progressive nephropathies ACE inhib-agonist, chronically administered to diabetic animals itors also inhibit the exaggerated synthesis of ET-1. with proteinuria, was shown to be effective as an ACE Thus ACE inhibitors given chronically to MWF/Ztm inhibitor in lowering blood pressure and controlling rats genetically targeted to glomerulosclerosis and total protein and albumin excretion [25] . Unselective progressive proteinuria [22] , as well as to animals inhibition of ET A and ET B receptors by bosentan had with immune mediated glomerulonephritis [23] , a beneficial effect on the evolution of nephritis in reduced renal ET-1 mRNA expression and the syn-experimental immune complex nephritis induced by repeated injections of ovoalbumin [18] . thesis of the parent peptide significantly.
Although inhibiting ACE is the best therapy available to date for animal and human proteinuric progressive nephropathies, such an approach alone is not always References sufficient to normalize urinary proteins or to fully prevent renal damage and GFR decline. Possible The diagnostic work-up of a patient with suspected of patients and save enormous costs [1] .
renal artery stenosis should always be directed towards Due to its non-invasiveness, lack of ionizing radiclarifying the issue if the surgical or interventional ation as well as use of non-nephrotoxic contrast media, revascularization is indicated. Thus, a single imaging magnetic resonance angiography (MRA) is a highly technique should ideally comprise a detailed evaluation promising screening technique. With the recent introof the morphology of the renovascular tree as well as duction of contrast-enhanced ultrafast techniques, MR an assessment of the degree of functional impairment angiograms with high spatial resolution can be of renal perfusion prior to intervention. In addition, acquired within a single breath-hold of less than the agreement between morphological, functional and 25 s. Typical limitations of unenhanced MRA such as haemodynamic abnormalities should be evaluated. motion artifacts or signal loss in small vessels can be Probably the most important question is to predict avoided. Therefore, MRA has now gained wide acceptwhether benefit will be derived from revascularization, ance for replacing more invasive procedures such as i.e. whether intervention is indicated. After surgery/ conventional X-ray angiography.
intervention the degree of improvement has to be The detection of renal artery stenosis with any assessed. imaging modality, however, represents only a first step Standard flow sensitive MRA techniques, such as in the diagnostic work-up of renovascular disease. The time-of-flight and phase-contrast angiography produce haemodynamic and functional significance of a detecangiograms by detecting the motion of flowing blood. ted lesion has to be assessed as well. these limitations by acquiring a complete three-period has become feasible ( Figure 1 ). This so-called 'multiphasic' approach helps to assess abnormalities in dimensional angiogram with high spatial resolution within a single breath-hold period [2] . This method, renal perfusion.
Further characterization of renal artery flow known as 3D gadolinium MR angiography, requires the administration of gadolinium-chelates as contrast dynamics can be performed by detection of turbulent flow. In unenhanced 3D phase-contrast-angiography media and therefore allows much faster image acquisition. However, with the current contrast agents, suffi-techniques, disturbance of the laminar flow pattern causes an artifactual signal dropout in the vessel [4, 6 ] cient vessel contrast is only available for a very short time during their first pass requiring optimum timing ( Figure 2 ). These haemodynamic abnormalites can be further quantified with 2D MR phase-contrast flow of the start of the measurement and infusion of the contrast agent. The technique provides true anatomic measurements, which can be directly combined with 3D gadolinium MR angiography. The different blood images with greatly improved image quality similar to conventional X-ray angiography. It also provides flow velocities within the vessel cross section can be mapped. This allows calculation of absolute blood flow adequate spatial resolution as high as 1.5 mm or less in all three dimensions. The gadolinium-chelates used values perpendicular to the vessel axis displayed on the MR angiogram [7] ( Table 1 ). The measurements for this procedure are not nephrotoxic and can be administered even in patients with severely compro-can be synchronized with the cardiac cycle (cardiac gating) and the pulsatility of blood flow can be mised renal function [3] . In addition, the method provides functional information of the renovascular recorded and plotted in velocity-or flow-time curves ( Figure 3 ). If these flow curves are recorded with high system and can be combined with quantitative MR techniques. Since ionizing radiation is not used in MR temporal resolution, characteristic flow profile changes are seen in stenotic vessels (Figure 4 ). The accuracy of imaging, there is no radiation hazard and a 3D gadolinium MRA scan can be repeated numerous times for this technique for quantification of mean blood flow as well as for detection of haemodynamic abnormalities the arterial, venous and excretory phases of the gadolinium passage. This allows temporal assessment of (i) has been proven in animal studies when the measurements could be directly correlated to invasive real time cortical and medullary enhancement, (ii) corticomedullary differentiation [4] , and (iii) the rate of excretion blood flow recordings [7] . In the past these techniques had acquisition times of several minutes. In contrast, of contrast media [5] . With the development of high performance MR systems, acquisition of multiple 3D today recently developed ultra fast MR techniques allows performance of these measurements within a angiography data sets within a single breath-hold single breath-hold period [8] (Figure 3 ). The morpho-and specificities >90% [11, 12] , if optimum timing of logical and haemodynamic parameters obtained can the measurement and the administration of contrast be correlated to data gained from standard imaging media is achieved. With common spatial resolutions such as kidney size and cortical thickness. ∏1.5 mm even accessory renal arteries can be assessed. For further quantification of renoparenchymal Further developments in contrast agents might even damage, quantitative assessment of the perfusion of improve this technique for detection of lesions in very renal tissue is necessary. Certain MR techniques which small distal/intrarenal or accessory vessels. can be used to determine the amount of blood inflow If a renal artery stenosis has been detected, a number into the parenchyma have been already successfully of studies must be performed to further characterize applied to the kidneys and the results are promising [9] . the haemodynamic and functional significance of the Diffusion imaging [10] might also help to further assess stenosis. The standard of reference for haemodynparenchymal damage. Both techniques have to be per-amic significance has been retrospectively defined as formed prior to administration of gadolinium-chelates. post-operative improvement, i.e. decrease of serum They can be easily included in the same MR session, creatinine, decrease of blood pressure/reduction of before the 3D gadolinium MR angiography and the antihypertensive medication [4] or prospectively as phase-contrast flow measurements are started, thereby demonstration of a trans-stenotic pressure gradient completing the concept of one comprehensive morpho->15 mmHg [6 ] or marked reduction of mean flow logical, haemodynamic and functional examination. [13] . In a comprehensive MR examination, different functional parameters can be identified which correlate
Role of comprehensive MR-imaging protocol
with the severity of stenosis. In the 3D gadolinium for detection and characterization of renal MRA, significant differences in parenchymal enhanceartery stenosis ment and cortical thickness were found between normal kidneys and those with haemodynamically significant stenoses [4] . Intravascular signal loss in 3D phase-3D gadolinium angiography allows reliable detection of a renal artery stenosis/aneurysm with sensitivities contrast angiography at the site of stenosis is also an accurate indicator of an haemodynamically significant stenosis [4, 6 ] . In MR phase-contrast flow measurements, (i) reduction of systolic blood flow velocities in the early systolic peak, and (ii) temporal delay of the systolic flow maximum are objective and accurate criteria that reflect haemodynamic abnormalities in significant renal artery stenoses. The sensitivity and specificity of these indices are comparable with that of DSA [13] . These results are superior to the ultrasound ( US) technique [14] , which is often compromised by poor visualization of renal anatomy due to overlay of bowel gas or fat. In addition, US assessment of the early systolic flow acceleration in the target vessels, i.e. the smaller intrarenal segmental arteries, is more influenced by downstream microangiopathic lesions.
The different MR imaging techniques analyze only Fig. 3 . Standard and ultra fast phase-contrast flow velocity measure-selected aspects of renovascular disease and conments obtained in the right renal artery of a 31-year-old healthy sequently none of these techniques has perfect sensitivvolunteer. The standard technique (continuous line) requires a scan ity and specificity [6 ] . As far as detection of changes time of several seconds with free breathing, the ultra fast technique in renal artery morphology is concerned, both DSA ( Table 2 ). In principle, if one detects an abnormality contrast (CINE-PC ) flow measurements in the renal artery.
in either of these techniques, one should suspect that or ionizing techniques with similar cost for contrast 13 (Figure 1) . normoalbuminuria, microalbuminuria or macroalbuminuria according to their albumin/creatinine ratio in Although the majority of diabetic patients with endstage renal failure who are admitted to dialysis are the urine samples obtained in the out-patient clinic.
The number of patients in each group is shown in supposed to suffer from non-insulin-dependent (type II ) diabetes mellitus, the precise proportion has not Table 1 . The prevalence of nephropathy is 14.6% if Correspondence and offprint requests to: Ryuichi Kikkawa, Shiga University School of Medicine, The third Department of Medicine, Seta, Otsu, Shiga 520-21, Japan. Table 1 . They studies indicated that microalbuminuria predicted not are older and the duration of diabetes is longer comonly the development of overt proteinuria but also a pared to type II diabetics without nephropathy. The high rate of cardiovascular death. As shown in Table 1 , prevalence of retinopathy and hypertension is higher, all-cause mortality was significantly higher in patients as expected from previous studies [3] . Interestingly, with microalbuminuria than in patients with normonearly 40% of type II diabetics without nephropathy, albuminuria. We recently completed a follow-up study i.e. normoalbuminuric patients, are hypertensive. The to clarify the relationship between microalbuminuria close association between hypertension and diabetes and cardiovascular death in Japanese subjects with has been previously reported. The observation suggests type II diabetes [6 ]. We followed 201 patients with that the two conditions share common pathogenetic normoalbuminuria and 96 with microalbuminuria for factors such as insulin resistance and hyperinsulinaemia an average of 6.4 years. During the follow-up period, [4] . In Japan normoalbuminuric type II diabetics are 28 deaths were confirmed (14 in normoalbuminuric not necessarily obese, and their average age is about and 14 in microalbuminuric patients). Only 10 deaths 58 years (see Table 1 ). Hypertension is so common in were attributed to cardiovascular disease (6 in norelderly Japanese that we cannot exclude the possibility moalbuminuric and 4 in microalbuminuric patients). that the coexistence of diabetes and hypertension Although the age-and sex-adjusted all-cause mortality occurs by chance [5] . rate in microalbuminuric patients was significantly higher than in normoalbuminuric patients (13.5 vs 8.2 per 1000 person years, P<0.05), the mortality rate
Prognosis of patients with type II diabetes and
from cardiovascular disease was not significantly nephropathy different between the two groups (3.4 vs 3.3 per 1000 person years). On age-adjusted Cox proportional Fifty-four of the 180 macroalbuminuric patients in hazards analysis, HbA1c and triglyceride were inde- Table 1 had progressed to end-stage renal failure during pendent risk factors for the mortality from cardioa 4-year observation period, but none of micro-and vascular disease, while microalbuminuria was not normoalbuminuric patients. Not unexpectedly, pro-associated with cardiovascular death [6 ] . Thus in gression to end-stage renal failure was more frequent Japanese patients with type II diabetes, in contrast to in patients with serum creatinine concentrations Caucasian patients, the existence of microalbuminuria >2 mg/dl (47/66, 71.2%). In our hospitals the preval-predicts the development of overt proteinuria [7] , but not cardiovascular death. ence of chronic renal failure is 5.4% among registered
